AACR-IO Poster - RedTail: A Next-Generation Systemic Platform for Tumor-Specific Delivery of BiTEs and Immune Activation

Calidi Biotherapeutics Inc. published this content on February 20, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on February 20, 2026 at 13:05 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]